4.3 Article

Livin is involved in TGF-β1-induced renal tubular epithelial-mesenchymal transition through lncRNA-ATB

Journal

ANNALS OF TRANSLATIONAL MEDICINE
Volume 7, Issue 18, Pages -

Publisher

AME PUBL CO
DOI: 10.21037/atm.2019.08.29

Keywords

Livin; transforming growth factor beta 1 (TGF-beta 1); epithelial-mesenchymal transition (EMT); lncRNA activated by TGF-beta (lncRNA-ATB); renal fibrosis

Funding

  1. 2015 Chinese Medicine Industry Research Specialized Chinese Medicine Treatment of Chronic Diseases Clinical Efficacy Study (1) Children's purpuric nephritis TCM treatment plan cohort study and chronic disease information management system [201507001-03]
  2. Correlation research of FAM3C and renal interstitial fibrosis
  3. Science and Technology Program of Shenyang City [F16-206-9-44]

Ask authors/readers for more resources

Background: Renal interstitial fibrosis is accepted as a crucial component of chronic kidney diseases (CKD). Epithelial-mesenchymal transition (EMT) is an important factor contributing to renal interstitial fibrosis. Livin, due to its ability to induce EMT, is an important regulator of many types of tumors and might also be involved in human renal tubular EMT. Methods: We confirmed that Livin and lncRNA-ATB could aggravate EMT in vivo and in vitro, lncRNA-ATB could be suppressed by the silencing of Livin whereas Livin expression was nearly stable when lncRNA-ATB was overexpressed or knocked out. Results: Livin was upregulated in vivo and in vitro at the similar rate as the occurrence of EMT, which could be relieved when Livin was silenced. LncRNA-ATB, which is another important regulator of EMT, was also found highly expressed during this process. The silencing of lncRNA-ATB could lessen the severity of EMT, and the overexpression of lncRNA-ATB could aggravate EMT without affecting the expression of Livin. Conclusions: Livin promotes EMT through the regulation of lncRNA-ATB. The silencing of Livin might be an effective targeted therapy for renal fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available